YPSN:SWX
Ypsomed Holding AG
CHF 357.80
arrow_downward
-0.83%(-3.00) 1D
Oct 2, 5:30:36 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YPSN...
Open
CHF 362.00
High
CHF 363.40
Low
CHF 357.20
Mkt. cap
4.68B
Avg. vol.
17.18K
Volume
7.60K
Dividend
1.23%
Quarterly dividend
CHF 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
21.94
52-wk high
CHF 418.00
52-wk low
CHF 260.50
EPS
CHF 16.31
Shares outstanding
13.15M
No. of employees
2K
Open
CHF 362.00
High
CHF 363.40
Low
CHF 357.20
Mkt. cap
4.68B
Avg. vol.
17.18K
Volume
7.60K
Dividend
1.23%
Quarterly dividend
CHF 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
21.94
52-wk high
CHF 418.00
52-wk low
CHF 260.50
EPS
CHF 16.31
Shares outstanding
13.15M
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
56 minutes ago
Long Lasting Symptom Relief Data Could Be A Game Changer For Vor Biopharma Stock
FXLeaders
·
1 hour ago
Dow Jones and Nasdaq Futures Open Higher as Buyers Target New Records
TipRanks
·
9 minutes ago
Chilwa Minerals Prices US Nasdaq IPO of ADSs and Warrants
Profile
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
About Ypsomed Holding AG